Please select the option that best describes you:

Is there any data comparing neoadjuvant pancreatic SBRT vs standard fractionation in terms of its ability to convert unresectable tumors to resectable tumors?  

What percentage of unresectable T4N0 pancreatic body adenocarcinomas with celiac axis involvement and no response to 6c chemo, will convert to resectable with 33 Gray in 5 fractions?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more